Current News from our Company
March highlights Autoimmune Awareness Month — a time to advance awareness, strengthen collaboration, and drive meaningful progress in autoimmune care. We are proud to mark this month with an important milestone: the expansion of our portfolio into...
Virion\Serion proudly announces the launch of our new Dengue Virus Type 2 Envelope Protein E (BA114R01), West Nile Virus Envelope Protein E (BA141R01) and West Nile Virus 6His-4ED3 Antigen (BA141VSR14).
Our latest SERION antigens designed for superior performance
Tailored Antigens for Highest CLIA Assay Performance - Recombinant Measles, Mumps, Rubella & Varicella Antigens.
SERION Immunologics Measles Virus Antigen - Premium was successfully applied in in-vitro stimulation assays to assess anti-tumor immunity induced by virotherapy.
A new microarray for the determination of a patient's vaccination status was developed by the InfectoGnostics Research Campus Jena.
Effecient removal of IgG antbodies for reliable IgM detection.